Catapres and Ukoniq drug interactions - a phase IV clinical study of FDA data
Summary:
We study 6,717 people who take Catapres (clonidine hydrochloride) and Ukoniq (umbralisib tosylate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Catapres and Ukoniq. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Catapres?
Catapres has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,680 Catapres users. Check the latest studies of Catapres.
What is Ukoniq?
Ukoniq has active ingredients of umbralisib tosylate. eHealthMe is studying from 37 Ukoniq users. Check the latest studies of Ukoniq.
No report is found.
Do you take Catapres and Ukoniq?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on clonidine hydrochloride and umbralisib tosylate (the active ingredients of Catapres and Ukoniq, respectively), and Catapres and Ukoniq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Bactrim and Calcium Ascorbate - 5 seconds ago
- Ondansetron and Bone And Joint Pain for Men aged 50-59 - 12 seconds ago
- Ondansetron and Joint Aches for Men aged 50-59 - 12 seconds ago
- Ondansetron and Stiffness In A Joint for Men aged 50-59 - 12 seconds ago
- Ondansetron and Pain - Joints for Men aged 50-59 - 13 seconds ago
- Ondansetron and Arthralgia for Men aged 50-59 - 13 seconds ago
- Ondansetron and Joint Pain for Men aged 50-59 - 13 seconds ago
- Drug interactions of Psorcon and Lisinopril - 17 seconds ago
- Pioglitazone and Isosorbide Mononitrate drug interactions for women aged 60+ - 22 seconds ago
- Could Acetazolamide cause Pulmonary Embolism? - 24 seconds ago